Total Payments
$3,145
2024 Payments
$175.05
Companies
22
Transactions
218
Medicare Patients
6,850
Medicare Billing
$412,547
Payment Breakdown by Category
Food & Beverage$2,892 (91.9%)
Education$253.48 (8.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,892 | 203 | 91.9% |
| Education | $253.48 | 15 | 8.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $647.92 | 49 | $0 (2024) |
| Amgen Inc. | $333.04 | 10 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $328.11 | 28 | $0 (2020) |
| Lilly USA, LLC | $313.03 | 29 | $0 (2024) |
| Astellas Pharma US Inc | $254.30 | 6 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $231.12 | 17 | $0 (2022) |
| GlaxoSmithKline, LLC. | $167.65 | 12 | $0 (2024) |
| Edwards Lifesciences Corporation | $148.29 | 2 | $0 (2019) |
| Radius Health, Inc. | $117.96 | 8 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $110.87 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $175.05 | 10 | Novo Nordisk Inc ($110.92) |
| 2023 | $315.00 | 16 | Amgen Inc. ($102.57) |
| 2022 | $66.90 | 4 | Amgen Inc. ($20.49) |
| 2021 | $13.89 | 1 | Amgen Inc. ($13.89) |
| 2020 | $77.79 | 5 | Novartis Pharmaceuticals Corporation ($30.24) |
| 2019 | $999.36 | 46 | Astellas Pharma US Inc ($230.03) |
| 2018 | $667.41 | 55 | Novartis Pharmaceuticals Corporation ($143.23) |
| 2017 | $829.99 | 81 | Novo Nordisk Inc ($169.59) |
All Payment Transactions
218 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Respiratory | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: RESPIRATORY | ||||||
| 08/13/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Diabetes | ||||||
| 04/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Diabetes | ||||||
| 01/30/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Diabetes | ||||||
| 01/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Respiratory | ||||||
| 12/12/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Oncology | ||||||
| 12/05/2023 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Bone Health | ||||||
| 11/17/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Diabetes | ||||||
| 11/14/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Diabetes | ||||||
| 09/14/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Endocrinology | ||||||
| 08/09/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Diabetes | ||||||
| 07/18/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Diabetes | ||||||
| 06/06/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Diabetes | ||||||
| 05/16/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Oncology | ||||||
| 05/11/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: RESPIRATORY | ||||||
| 05/04/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Diabetes | ||||||
| 03/14/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $84.37 | General |
| Category: Cardiology | ||||||
| 01/26/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: RESPIRATORY | ||||||
| 01/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,557 | 2,413 | $213,485 | $104,047 |
| 2022 | 27 | 1,550 | 2,283 | $315,879 | $93,886 |
| 2021 | 31 | 1,829 | 2,720 | $383,638 | $112,792 |
| 2020 | 32 | 1,914 | 2,799 | $338,870 | $101,822 |
Total Patients
6,850
Total Services
10,215
Medicare Billing
$412,547
Procedure Codes
113
All Medicare Procedures & Services
113 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 105 | 217 | $30,580 | $18,821 | 61.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 130 | 271 | $27,235 | $15,928 | 58.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 54 | 134 | $17,420 | $12,187 | 70.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 164 | 176 | $27,600 | $8,794 | 31.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 44 | 54 | $12,690 | $6,956 | 54.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 58 | 76 | $13,300 | $6,728 | 50.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 23 | 30 | $9,750 | $6,386 | 65.5% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 28 | 37 | $9,065 | $5,636 | 62.2% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 376 | 794 | $19,850 | $4,567 | 23.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 35 | 35 | $7,525 | $4,372 | 58.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 11 | 24 | $8,280 | $4,043 | 48.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 23 | 25 | $4,125 | $2,382 | 57.8% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 143 | 154 | $5,390 | $1,341 | 24.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 89 | 90 | $4,500 | $1,322 | 29.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 17 | $1,615 | $1,056 | 65.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 16 | 22 | $2,105 | $1,002 | 47.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 88 | 89 | $3,560 | $871.20 | 24.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 14 | 14 | $980.00 | $560.56 | 57.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 37 | 40 | $1,400 | $308.24 | 22.0% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 40 | 40 | $2,500 | $295.26 | 11.8% |
| 94618 | Test for exercise-induced lung stress | Facility | 2023 | 14 | 14 | $805.00 | $242.06 | 30.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 36 | 36 | $2,610 | $228.69 | 8.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 18 | 24 | $600.00 | $18.77 | 3.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 285 | $72,278 | $23,699 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 106 | 184 | $35,706 | $10,335 | 28.9% |
About Dr. Muhammed Mirza, MD
Dr. Muhammed Mirza, MD is a Internal Medicine healthcare provider based in Standish, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437156015.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammed Mirza, MD has received a total of $3,145 in payments from pharmaceutical and medical device companies, with $175.05 received in 2024. These payments were reported across 218 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($2,892).
As a Medicare-enrolled provider, Mirza has provided services to 6,850 Medicare beneficiaries, totaling 10,215 services with total Medicare billing of $412,547. Data is available for 4 years (2020–2023), covering 113 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Standish, MI
- Active Since 06/28/2005
- Last Updated 12/23/2009
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437156015
Products in Payments
- ENTRESTO (Drug) $328.11
- Victoza (Drug) $225.11
- Repatha (Biological) $209.37
- Ozempic (Drug) $206.64
- XARELTO (Drug) $192.10
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $135.29
- SOLIQUA (Drug) $103.61
- Tymlos (Biological) $101.32
- Tresiba (Drug) $93.21
- Rybelsus (Drug) $81.80
- TRELEGY ELLIPTA (Drug) $81.19
- HUMALOG (Drug) $76.25
- FORTEO (Drug) $75.03
- Prolia (Biological) $71.09
- ANORO (Drug) $62.18
- VIBERZI (Drug) $53.16
- TRULICITY (Drug) $51.28
- ELIQUIS (Drug) $50.57
- JANUVIA (Drug) $50.48
- MOUNJARO (Drug) $50.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.